Key highlights:

• Amaero secured a A$6.51 million (US$4.5 million) contract from the US Department of War to develop alternative refractory alloy powders, its second active US government revenue stream in under a year.

• FY2026 full-year revenue reached A$18.1 million, a 376% increase on the prior year, with Q4 revenue alone up 417% to A$7.8 million, landing inside the A$18–20 million guidance range.

• Backlog rose from A$14.6 million at quarter-end to A$23.1 million by 22 July after fresh wins, while commissioned capacity has doubled titanium powder output to around 480 metric tonnes per year.

For most of its listed life, Amaero International (ASX:3DA) has been a story about potential rather than proof. That balance is beginning to shift. On 22 July 2026 the company confirmed a A$6.51 million (US$4.5 million) contract from the United States Department of War to develop alternative refractory alloy powders, a niche but strategically important corner of the defence supply chain.

The award is modest in dollar terms, but it lands as Washington grows anxious about its dependence on foreign-sourced critical materials. For a small-cap Australian manufacturer that has moved its centre of gravity to Tennessee, it is another signal that Amaero is being taken seriously by the US military-industrial establishment. Shares rose almost 10% as the news landed alongside a record quarterly result.

Company Overview

Amaero produces high-value refractory and titanium alloy powders used in additive and advanced manufacturing across the defence, space, aviation and medical industries. Though ASX-listed, its manufacturing headquarters and strategic focus now sit firmly in Tennessee.

The business rests on two pillars: metal powder production using EIGA (Electrode Induction Melting Inert Gas) atomisation, positioned as among the most advanced for demanding refractory alloys, and component manufacturing through powder metallurgy hot isostatic pressing, or PM-HIP. Chairman and chief executive Hank J. Holland has steered the group towards US defence reshoring, betting domestic supply of critical alloys will command a premium as geopolitical tension deepens.

Latest News

Over roughly 13 months, to completion in August 2027, Amaero will develop alternative refractory alloy powders that reduce cost and cut US reliance on foreign critical raw materials. The reference material is Niobium C103, an aerospace alloy of about 89% niobium, 10% hafnium and 1% titanium used in hypersonic and space propulsion.

The economic driver is stark. Hafnium prices have surged more than 700% over three years to around US$12,500 per kilogram, making traditional C103 increasingly expensive, and Amaero's task is to down-select cheaper, domestically securable alternatives. Revenue will be recognised progressively, roughly 40% in the second half of calendar 2026 and about 50% across the first half of 2027. Crucially, it is the company's second active US government revenue stream, after a US Navy submarine programme secured earlier in 2026.

Why Investors Are Watching

The appeal is straightforward: Amaero is one of very few companies able to supply refractory and titanium alloy powders at scale on US soil, exactly the capability American defence planners are scrambling to onshore. A second government revenue stream in a year suggests it is becoming an embedded partner.

Sentiment, however, remains fragile. Despite the July jump to around A$0.28, the stock sat roughly 40% lower over the preceding year. Investors want to know whether soaring revenue can translate into positive cash generation and repeatable, high-margin production.

Growth Opportunities

Capacity is the clearest growth lever. Amaero has commissioned its third EIGA premium atomiser, completing a roughly A$72 million programme that has doubled titanium powder capacity to about 480 metric tonnes a year, giving room for larger, recurring orders as US demand builds.

Commercial momentum is following, with a Master Purchasing Agreement carrying a A$7.8 million minimum titanium powder commitment for FY2027. If the Department of War programme identifies viable C103 alternatives, Amaero could be first in line to manufacture them at volume, turning a development contract into a long-term production franchise.

Risks

Execution risk is real and recent. On 13 May 2026 a flash fire during manufacturing at the Tennessee facility injured two production team members, prompting a safety-first pause of titanium powder production for about six weeks while consultant Jensen Hughes reviewed facility design and process safety. Around A$1.3 million of orders slipped into FY2027, though there were no purchase-order cancellations or staff attrition during the pause.

The financial profile also carries risk. A double-digit-million quarterly cash outflow against a cash balance under A$20 million means capital discipline, and potentially further raisings, remain live considerations. Defence contracts are also lumpy and exposed to shifting government priorities, and much of the case rests on converting development work into sustained supply.

Industry Outlook

The macro backdrop is arguably Amaero's strongest tailwind. The United States is actively reshoring critical materials capability, wary of supply chains that run through geopolitical rivals for inputs such as niobium and hafnium, and domestic powder supply for hypersonic, space and naval programmes is a recognised bottleneck.

Against that setting, a company with commissioned US atomisation capacity and a growing government track record is well placed. The hafnium spike underlines why a domestic partner able to develop and produce alternatives holds value well beyond the headline contract size.

What to Watch Next

Three markers matter over the coming quarters. First, cash: whether the operating outflow narrows as revenue scales, and whether growth can be funded without heavily diluting shareholders. Second, delivery: smooth resumption of titanium production and clean execution against the backlog due by December 2026.

Third, conversion: progress on the Department of War programme's milestone payments into 2027, and any signal that development work is heading towards volume production. Further wins under the Master Purchasing Agreement, or a deeper Navy relationship, would show Amaero becoming a fixture in US defence supply rather than an occasional contractor.

Conclusion

Amaero's A$6.5 million Department of War award is not, on its own, a company-defining number. Its significance lies in what it represents: a second US government revenue stream inside a year, validation of the firm's refractory-alloy capability, and alignment with a powerful US reshoring theme.

The counterweight is a business still burning cash, recovering from a safety-driven pause and trading well below where it stood a year ago. The question is whether record revenue growth and a lengthening list of defence relationships can mature into durable, cash-generative supply. The coming quarters should offer a clearer answer. This article is editorial journalism and general information only, not investment advice.